National Health Investors (NYSE:NHI) Upgraded at StockNews.com

StockNews.com upgraded shares of National Health Investors (NYSE:NHI) from a hold rating to a buy rating in a research report released on Monday.

Other equities research analysts have also recently issued research reports about the company. Stifel Nicolaus restated a hold rating and set a $55.00 price objective on shares of National Health Investors in a report on Tuesday, November 28th. Deutsche Bank Aktiengesellschaft began coverage on National Health Investors in a report on Tuesday, January 30th. They issued a buy rating and a $69.00 target price on the stock. Wedbush lifted their target price on National Health Investors from $64.00 to $66.00 and gave the company an outperform rating in a report on Monday, March 18th. BMO Capital Markets upgraded National Health Investors from a market perform rating to an outperform rating and set a $67.00 target price on the stock in a report on Tuesday, March 12th. Finally, Wells Fargo & Company raised National Health Investors from an equal weight rating to an overweight rating and raised their price objective for the company from $55.00 to $63.00 in a research report on Monday, February 26th. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, National Health Investors currently has an average rating of Moderate Buy and a consensus target price of $59.22.

National Health Investors Stock Performance

NYSE NHI opened at $62.83 on Monday. National Health Investors has a 1-year low of $47.54 and a 1-year high of $62.93. The company has a market capitalization of $2.73 billion, a P/E ratio of 20.07 and a beta of 0.94. The business has a 50 day moving average price of $56.76 and a 200 day moving average price of $54.29. The company has a debt-to-equity ratio of 0.90, a current ratio of 10.27 and a quick ratio of 10.27.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 3rd. Investors of record on Thursday, March 28th will be paid a $0.90 dividend. The ex-dividend date is Wednesday, March 27th. This represents a $3.60 dividend on an annualized basis and a yield of 5.73%. National Health Investors’s dividend payout ratio (DPR) is 115.02%.

Insider Buying and Selling at National Health Investors

In related news, Director Charlotte A. Swafford bought 10,000 shares of the firm’s stock in a transaction on Tuesday, February 27th. The stock was bought at an average cost of $58.69 per share, for a total transaction of $586,900.00. Following the completion of the purchase, the director now directly owns 110,185 shares in the company, valued at approximately $6,466,757.65. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 7.26% of the stock is currently owned by insiders.

Hedge Funds Weigh In On National Health Investors

Hedge funds and other institutional investors have recently made changes to their positions in the business. Norges Bank bought a new stake in National Health Investors during the fourth quarter worth approximately $25,448,000. Waterfront Capital Partners LLC bought a new position in shares of National Health Investors in the fourth quarter valued at $21,863,000. State Street Corp increased its holdings in shares of National Health Investors by 15.9% in the first quarter. State Street Corp now owns 2,186,194 shares of the real estate investment trust’s stock valued at $130,904,000 after buying an additional 299,737 shares in the last quarter. Millennium Management LLC increased its holdings in shares of National Health Investors by 7,218.8% in the second quarter. Millennium Management LLC now owns 258,574 shares of the real estate investment trust’s stock valued at $15,672,000 after buying an additional 255,041 shares in the last quarter. Finally, Land & Buildings Investment Management LLC bought a new position in shares of National Health Investors in the third quarter valued at $11,642,000. 62.51% of the stock is currently owned by institutional investors and hedge funds.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.